Transdermal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Pages: 411 Published: July 29, 2022 Report Code: GDME1414EPD

Transdermal drug delivery devices is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal drug delivery pipeline market research report provides comprehensive information about the transdermal drug delivery devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Territories in the Transdermal Drug Delivery Pipeline Market

The key territories in the transdermal drug delivery pipeline market are the United States, Europe, South Korea, Canada, Japan, China, and Australia. The United States has the highest number of pipeline products.

Transdermal Drug Delivery Pipeline Market, by Territories

Transdermal Drug Delivery Pipeline Market, by Territories

For more territory insights, download a free report sample

Key Categories in the Transdermal Drug Delivery Pipeline Market

The key categories in the transdermal drug delivery pipeline market are Active Formulations and Passive Formulations. Active Formulations has the highest number of pipeline products.

Transdermal Drug Delivery Pipeline Market, by Categories

Transdermal Drug Delivery Pipeline Market, by Categories

For more category insights, download a free report sample

Key Regulatory Paths in the Transdermal Drug Delivery Pipeline Market

The key regulatory paths in the transdermal drug delivery pipeline market are 510(k), CE, MDITAC, MDL, Ninsho, NMPA, TGA, and BOPA. 510(k) has the highest number of pipeline products.

Transdermal Drug Delivery Pipeline Market, by Regulatory Paths

Transdermal Drug Delivery Pipeline Market, by Regulatory Paths

For more regulatory path insights, download a free report sample

Key Companies in the Transdermal Drug Delivery Pipeline Market

The key companies in the transdermal drug delivery pipeline market are 4P Therapeutics LLC, Actuated Medical Inc, Adynxx Inc, Aequus Pharmaceuticals Inc, AerMedX Ltd, and Agile Therapeutics Inc, Allergan Ltd, American Chemical Society, and AMW GmbH.

Market report overview

Key territories The United States, Europe, South Korea, Canada, Japan, China, and Australia
Key categories Active Formulations and Passive Formulations
Key regulatory paths 510(k), CE, MDITAC, MDL, Ninsho, NMPA, TGA, and BOPA
Key companies 4P Therapeutics LLC, Actuated Medical Inc, Adynxx Inc, Aequus Pharmaceuticals Inc, AerMedX Ltd, and Agile Therapeutics Inc, Allergan Ltd, American Chemical Society, and AMW GmbH

Scope

Extensive coverage of the transdermal drug delivery devices under development.

  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities.
  • The report reviews the major players involved in the development of transdermal drug delivery devices and lists all their pipeline projects.
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage.
  • The report provides key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Identify and understand important and diverse types of transdermal drug delivery devices under development.
  • Develop market-entry and market expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Key Players

4P Therapeutics LLC
Actuated Medical Inc
Adynxx Inc
Aequus Pharmaceuticals Inc
AerMedX Ltd
Agile Therapeutics Inc
Allergan Ltd
American Chemical Society
AMW GmbH
Apogee Technology Inc
Asahi Kasei Pharma Corp
ASCIL Biopharm
Avecho Biotechnology Ltd
Avro Life Sciences
Boryung Pharmaceutical Co Ltd
Burke Pharmaceuticals LLC
Candesant Biomedical Inc
Cassava Sciences Inc
CB Scientific Inc
Cerimon Pharmaceuticals, Inc. (Inactive)
Chrono Therapeutics Inc
Cipla Ltd
Clexio Biosciences Ltd
Corium Inc
Daewoong Pharmaceutical Co Ltd
DBV Technologies SA
DD Therapeutics LLC
Delpor Inc
Dermisonics Inc
Dharma Therapeutics, Inc. (Inactive)
Diomics Corp
Drexel University
Drug Delivery Co LLC
DURECT Corp
Echo Therapeutics Inc
Emplicure AB
Endo International Plc
Endomimetics LLC
Extend Biosciences Inc
Fe3 Medical Inc
Futura Medical Plc
Georgia Institute of Technology
Georgia State University
GlobeStar Therapeutics Corp
Hisamitsu Pharmaceutical Co Inc
I M Sechenov Moscow State Medical University
Icure Pharmaceutical Inc
ImmunoMatrix LLC
ImmuPatch
Indian Institute of Science
Indian Institute of Technology Bombay
Indian Institute of Technology Hyderabad
InMed Pharmaceuticals Inc
Institute of Materials Research & Engineering
Intercell AG (Inactive)
Interstitial NS
Isis Biopolymer Inc (Inactive)
Janisys
Jiaxing Xinwen Biotechnology Co Ltd
Jubilee Biotech
Kailian Medical Technology Co Ltd
Karolinska Institute
Kindeva Drug Delivery LP
KTH Royal Institute of Technology
Leo Pharma AS
Livzon Pharmaceutical Group Co Ltd
Lohmann Therapie-Systeme AG
Luye Pharma Group Ltd
Massachusetts Institute of Technology
Mayne Pharma Group Ltd
Medherant Ltd
MEDRx Co Ltd
MedRx, Inc.
Microdermics Inc
Micron Biomedical Inc
Micropoint Technologies Pte Ltd
Mineed Technology Co Ltd
mPhase Technologies Inc
Mycrodose Therapeutics Inc
MyLife Technologies
Nanyang Technological University
National Dental Centre Singapore
National University of Singapore
Nemaura Pharma Ltd
NeuroDerm Ltd
Nitto Denko Corp
North Carolina State University
Noven Pharmaceuticals Inc
NutriBand Inc
Nuvo Pharmaceuticals Inc
Osprey Medical Inc
Pantec Biosolutions AG
PassPort Technologies Inc
PharmaTher Holdings Ltd
Privo Technologies Inc
Prometheon Pharma LLC
Purdue University
Quadmedicine
Quoin Pharmaceuticals Inc
Radius Health Inc
Ryah Medtech Inc
Samyang Biopharmaceuticals Corp
Sanofi
Seelos Therapeutics, Inc.
Shenox Pharmaceuticals LLC
Sinsin Pharmaceutical Co Ltd
SK Chemicals Co Ltd
Skinject Inc
Sorrento Therapeutics Inc
Sparsha Pharma International Pvt Ltd
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Stanford University
Starton Therapeutics Inc
Swansea University
Syntropharma Ltd
Taho Pharmaceuticals Ltd
Technology Health Inc
Teikoku Pharma USA Inc
tesa Labtec GmbH
Teva Pharmaceutical Industries Ltd
Texas Tech University
The Sheikh Zayed Institute for Pediatric Surgical Innovation
TheraJect Inc
TheraSolve NV (Inactive)
Theratech, Inc.
Theris Medical Inc
Thrudermic LLC
Titan Pharmaceuticals Inc
Toa Eiyo Ltd
Transcu Group Limited (Inactive)
Transdermal Delivery Solutions Corp
TransPharma Medical Ltd (Inactive)
Transport Pharmaceuticals Inc
University of Helsinki
University of Illinois at Chicago
University of South Florida
University of Tokyo
University of Toronto
University of Washington
Vaxess Technologies Inc
Vaxxas Pty Ltd
Verndari Inc
ViiV Healthcare UK Ltd
Virpax Pharmaceuticals Inc
Vyteris, Inc. (Inactive)
Wellfully Ltd
Xel Pharmaceuticals Inc
XPhyto Therapeutics Corp
Zambon Italia Srl
Z-Cube Srl
ZetrOZ Inc
Zosano Pharma Corp
Zylo Therapeutics LLC
Zynerba Pharmaceuticals Inc

Table of Contents

1 Table of Contents 3

|1.1 List of Tables 11

|1.2 List of Figures 26

2 Introduction 27

2.1 Transdermal Drug Delivery Overview 27

3 Products under Development 28

3.1 Transdermal Drug Delivery – Pipeline Products by Stage of Development 28

3.2 Transdermal Drug Delivery – Pipeline Products by Segment 29

3.3 Transdermal Drug Delivery – Pipeline Products by Territory 30

3.4 Transdermal Drug Delivery – Pipeline Products by Regulatory Path 32

3.5 Transdermal Drug Delivery – Pipeline Products by Estimated Approval Date 33

3.6 Transdermal Drug Delivery – Ongoing Clinical Trials 34

4 Transdermal Drug Delivery – Pipeline Products under Development by Companies 35

4.1 Transdermal Drug Delivery Companies – Pipeline Products by Stage of Development 35

4.2 Transdermal Drug Delivery – Pipeline Products by Stage of Development 41

5 Transdermal Drug Delivery Companies and Product Overview 48

5.1 4P Therapeutics LLC Company Overview 48

5.1.1 4P Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 48

5.2 Actuated Medical Inc Company Overview 57

5.2.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 57

5.3 Adynxx Inc Company Overview 58

5.3.1 Adynxx Inc Pipeline Products & Ongoing Clinical Trials Overview 58

5.4 Aequus Pharmaceuticals Inc Company Overview 59

5.4.1 Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.5 AerMedX Ltd Company Overview 63

5.5.1 AerMedX Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

5.6 Agile Therapeutics Inc Company Overview 64

5.6.1 Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.7 Allergan Ltd Company Overview 67

5.7.1 Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview 67

5.8 American Chemical Society Company Overview 69

5.8.1 American Chemical Society Pipeline Products & Ongoing Clinical Trials Overview 69

5.9 AMW GmbH Company Overview 70

5.9.1 AMW GmbH Pipeline Products & Ongoing Clinical Trials Overview 70

5.10 Apogee Technology Inc Company Overview 72

5.10.1 Apogee Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 72

5.11 Asahi Kasei Pharma Corp Company Overview 73

5.11.1 Asahi Kasei Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview 73

5.12 ASCIL Biopharm Company Overview 74

5.12.1 ASCIL Biopharm Pipeline Products & Ongoing Clinical Trials Overview 74

5.13 Avecho Biotechnology Ltd Company Overview 75

5.13.1 Avecho Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview 75

5.14 Avro Life Sciences Company Overview 78

5.14.1 Avro Life Sciences Pipeline Products & Ongoing Clinical Trials Overview 78

5.15 Boryung Pharmaceutical Co Ltd Company Overview 80

5.15.1 Boryung Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

5.16 Burke Pharmaceuticals LLC Company Overview 81

5.16.1 Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 81

5.17 Candesant Biomedical Inc Company Overview 83

5.17.1 Candesant Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 83

5.18 Cassava Sciences Inc Company Overview 86

5.18.1 Cassava Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 86

5.19 CB Scientific Inc Company Overview 87

5.19.1 CB Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 87

5.20 Cerimon Pharmaceuticals, Inc. (Inactive) Company Overview 88

5.20.1 Cerimon Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 88

5.21 Chrono Therapeutics Inc Company Overview 89

5.21.1 Chrono Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 89

5.22 Cipla Ltd Company Overview 90

5.22.1 Cipla Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

5.23 Clexio Biosciences Ltd Company Overview 91

5.23.1 Clexio Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 91

5.24 Corium Inc Company Overview 92

5.24.1 Corium Inc Pipeline Products & Ongoing Clinical Trials Overview 92

5.25 Daewoong Pharmaceutical Co Ltd Company Overview 98

5.25.1 Daewoong Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 98

5.26 DBV Technologies SA Company Overview 99

5.26.1 DBV Technologies SA Pipeline Products & Ongoing Clinical Trials Overview 99

5.27 DD Therapeutics LLC Company Overview 104

5.27.1 DD Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 104

5.28 Delpor Inc Company Overview 105

5.28.1 Delpor Inc Pipeline Products & Ongoing Clinical Trials Overview 105

5.29 Dermisonics Inc Company Overview 109

5.29.1 Dermisonics Inc Pipeline Products & Ongoing Clinical Trials Overview 109

5.30 Dharma Therapeutics, Inc. (Inactive) Company Overview 110

5.30.1 Dharma Therapeutics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 110

5.31 Diomics Corp Company Overview 111

5.31.1 Diomics Corp Pipeline Products & Ongoing Clinical Trials Overview 111

5.32 Drexel University Company Overview 112

5.32.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 112

5.33 Drug Delivery Co LLC Company Overview 113

5.33.1 Drug Delivery Co LLC Pipeline Products & Ongoing Clinical Trials Overview 113

5.34 DURECT Corp Company Overview 114

5.34.1 DURECT Corp Pipeline Products & Ongoing Clinical Trials Overview 114

5.35 Echo Therapeutics Inc Company Overview 116

5.35.1 Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 116

5.36 Emplicure AB Company Overview 117

5.36.1 Emplicure AB Pipeline Products & Ongoing Clinical Trials Overview 117

5.37 Endo International Plc Company Overview 118

5.37.1 Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview 118

5.38 Endomimetics LLC Company Overview 119

5.38.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview 119

5.39 Extend Biosciences Inc Company Overview 120

5.39.1 Extend Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 120

5.40 Fe3 Medical Inc Company Overview 121

5.40.1 Fe3 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 121

5.41 Futura Medical Plc Company Overview 122

5.41.1 Futura Medical Plc Pipeline Products & Ongoing Clinical Trials Overview 122

5.42 Georgia Institute of Technology Company Overview 126

5.42.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 126

5.43 Georgia State University Company Overview 129

5.43.1 Georgia State University Pipeline Products & Ongoing Clinical Trials Overview 129

5.44 GlobeStar Therapeutics Corp Company Overview 130

5.44.1 GlobeStar Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 130

5.45 Hisamitsu Pharmaceutical Co Inc Company Overview 131

5.45.1 Hisamitsu Pharmaceutical Co Inc Pipeline Products & Ongoing Clinical Trials Overview 131

5.46 I M Sechenov Moscow State Medical University Company Overview 136

5.46.1 I M Sechenov Moscow State Medical University Pipeline Products & Ongoing Clinical Trials Overview 136

5.47 Icure Pharmaceutical Inc Company Overview 137

5.47.1 Icure Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview 137

5.48 ImmunoMatrix LLC Company Overview 141

5.48.1 ImmunoMatrix LLC Pipeline Products & Ongoing Clinical Trials Overview 141

5.49 ImmuPatch Company Overview 142

5.49.1 ImmuPatch Pipeline Products & Ongoing Clinical Trials Overview 142

5.50 Indian Institute of Science Company Overview 144

5.50.1 Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 144

5.51 Indian Institute of Technology Bombay Company Overview 145

5.51.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 145

5.52 Indian Institute of Technology Hyderabad Company Overview 146

5.52.1 Indian Institute of Technology Hyderabad Pipeline Products & Ongoing Clinical Trials Overview 146

5.53 InMed Pharmaceuticals Inc Company Overview 147

5.53.1 InMed Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 147

5.54 Institute of Materials Research & Engineering Company Overview 148

5.54.1 Institute of Materials Research & Engineering Pipeline Products & Ongoing Clinical Trials Overview 148

5.55 Intercell AG (Inactive) Company Overview 149

5.55.1 Intercell AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 149

5.56 Interstitial NS Company Overview 150

5.56.1 Interstitial NS Pipeline Products & Ongoing Clinical Trials Overview 150

5.57 Isis Biopolymer Inc (Inactive) Company Overview 151

5.57.1 Isis Biopolymer Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 151

5.58 Janisys Company Overview 153

5.58.1 Janisys Pipeline Products & Ongoing Clinical Trials Overview 153

5.59 Jiaxing Xinwen Biotechnology Co Ltd Company Overview 154

5.59.1 Jiaxing Xinwen Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 154

5.60 Jubilee Biotech Company Overview 156

5.60.1 Jubilee Biotech Pipeline Products & Ongoing Clinical Trials Overview 156

5.61 Kailian Medical Technology Co Ltd Company Overview 157

5.61.1 Kailian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 157

5.62 Karolinska Institute Company Overview 158

5.62.1 Karolinska Institute Pipeline Products & Ongoing Clinical Trials Overview 158

5.63 Kindeva Drug Delivery LP Company Overview 159

5.63.1 Kindeva Drug Delivery LP Pipeline Products & Ongoing Clinical Trials Overview 159

5.64 KTH Royal Institute of Technology Company Overview 160

5.64.1 KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 160

5.65 Leo Pharma AS Company Overview 161

5.65.1 Leo Pharma AS Pipeline Products & Ongoing Clinical Trials Overview 161

5.66 Livzon Pharmaceutical Group Co Ltd Company Overview 164

5.66.1 Livzon Pharmaceutical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 164

5.67 Lohmann Therapie-Systeme AG Company Overview 165

5.67.1 Lohmann Therapie-Systeme AG Pipeline Products & Ongoing Clinical Trials Overview 165

5.68 Luye Pharma Group Ltd Company Overview 167

5.68.1 Luye Pharma Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 167

5.69 Massachusetts Institute of Technology Company Overview 170

5.69.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 170

5.70 Mayne Pharma Group Ltd Company Overview 171

5.70.1 Mayne Pharma Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 171

5.71 Medherant Ltd Company Overview 172

5.71.1 Medherant Ltd Pipeline Products & Ongoing Clinical Trials Overview 172

5.72 MEDRx Co Ltd Company Overview 177

5.72.1 MEDRx Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 177

5.73 MedRx, Inc. Company Overview 183

5.73.1 MedRx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 183

5.74 Microdermics Inc Company Overview 184

5.74.1 Microdermics Inc Pipeline Products & Ongoing Clinical Trials Overview 184

5.75 Micron Biomedical Inc Company Overview 185

5.75.1 Micron Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 185

5.76 Micropoint Technologies Pte Ltd Company Overview 189

5.76.1 Micropoint Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 189

5.77 Mineed Technology Co Ltd Company Overview 190

5.77.1 Mineed Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 190

5.78 mPhase Technologies Inc Company Overview 191

5.78.1 mPhase Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 191

5.79 Mycrodose Therapeutics Inc Company Overview 192

5.79.1 Mycrodose Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 192

5.80 MyLife Technologies Company Overview 194

5.80.1 MyLife Technologies Pipeline Products & Ongoing Clinical Trials Overview 194

5.81 Nanyang Technological University Company Overview 195

5.81.1 Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview 195

5.82 National Dental Centre Singapore Company Overview 196

5.82.1 National Dental Centre Singapore Pipeline Products & Ongoing Clinical Trials Overview 196

5.83 National University of Singapore Company Overview 197

5.83.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 197

5.84 Nemaura Pharma Ltd Company Overview 199

5.84.1 Nemaura Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 199

5.85 NeuroDerm Ltd Company Overview 207

5.85.1 NeuroDerm Ltd Pipeline Products & Ongoing Clinical Trials Overview 207

5.86 Nitto Denko Corp Company Overview 209

5.86.1 Nitto Denko Corp Pipeline Products & Ongoing Clinical Trials Overview 209

5.87 North Carolina State University Company Overview 212

5.87.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 212

5.88 Noven Pharmaceuticals Inc Company Overview 214

5.88.1 Noven Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 214

5.89 NutriBand Inc Company Overview 216

5.89.1 NutriBand Inc Pipeline Products & Ongoing Clinical Trials Overview 216

5.90 Nuvo Pharmaceuticals Inc Company Overview 221

5.90.1 Nuvo Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 221

5.91 Osprey Medical Inc Company Overview 222

5.91.1 Osprey Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 222

5.92 Pantec Biosolutions AG Company Overview 223

5.92.1 Pantec Biosolutions AG Pipeline Products & Ongoing Clinical Trials Overview 223

5.93 PassPort Technologies Inc Company Overview 227

5.93.1 PassPort Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 227

5.94 PharmaTher Holdings Ltd Company Overview 228

5.94.1 PharmaTher Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 228

5.95 Privo Technologies Inc Company Overview 231

5.95.1 Privo Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 231

5.96 Prometheon Pharma LLC Company Overview 232

5.96.1 Prometheon Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview 232

5.97 Purdue University Company Overview 235

5.97.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 235

5.98 Quadmedicine Company Overview 237

5.98.1 Quadmedicine Pipeline Products & Ongoing Clinical Trials Overview 237

5.99 Quoin Pharmaceuticals Inc Company Overview 239

5.99.1 Quoin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 239

5.100 Radius Health Inc Company Overview 241

5.100.1 Radius Health Inc Pipeline Products & Ongoing Clinical Trials Overview 241

5.101 Ryah Medtech Inc Company Overview 242

5.101.1 Ryah Medtech Inc Pipeline Products & Ongoing Clinical Trials Overview 242

5.102 Samyang Biopharmaceuticals Corp Company Overview 243

5.102.1 Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 243

5.103 Sanofi Company Overview 244

5.103.1 Sanofi Pipeline Products & Ongoing Clinical Trials Overview 244

5.104 Seelos Therapeutics, Inc. Company Overview 245

5.104.1 Seelos Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 245

5.105 Shenox Pharmaceuticals LLC Company Overview 246

5.105.1 Shenox Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 246

5.106 Sinsin Pharmaceutical Co Ltd Company Overview 251

5.106.1 Sinsin Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 251

5.107 SK Chemicals Co Ltd Company Overview 254

5.107.1 SK Chemicals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 254

5.108 Skinject Inc Company Overview 255

5.108.1 Skinject Inc Pipeline Products & Ongoing Clinical Trials Overview 255

5.109 Sorrento Therapeutics Inc Company Overview 258

5.109.1 Sorrento Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 258

5.110 Sparsha Pharma International Pvt Ltd Company Overview 259

5.110.1 Sparsha Pharma International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 259

5.111 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 260

5.111.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 260

5.112 Stanford University Company Overview 261

5.112.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 261

5.113 Starton Therapeutics Inc Company Overview 263

5.113.1 Starton Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 263

5.114 Swansea University Company Overview 272

5.114.1 Swansea University Pipeline Products & Ongoing Clinical Trials Overview 272

5.115 Syntropharma Ltd Company Overview 273

5.115.1 Syntropharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 273

5.116 Taho Pharmaceuticals Ltd Company Overview 275

5.116.1 Taho Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 275

5.117 Technology Health Inc Company Overview 278

5.117.1 Technology Health Inc Pipeline Products & Ongoing Clinical Trials Overview 278

5.118 Teikoku Pharma USA Inc Company Overview 279

5.118.1 Teikoku Pharma USA Inc Pipeline Products & Ongoing Clinical Trials Overview 279

5.119 tesa Labtec GmbH Company Overview 283

5.119.1 tesa Labtec GmbH Pipeline Products & Ongoing Clinical Trials Overview 283

5.120 Teva Pharmaceutical Industries Ltd Company Overview 285

5.120.1 Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview 285

5.121 Texas Tech University Company Overview 286

5.121.1 Texas Tech University Pipeline Products & Ongoing Clinical Trials Overview 286

5.122 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview 287

5.122.1 The Sheikh Zayed Institute for Pediatric Surgical Innovation Pipeline Products & Ongoing Clinical Trials Overview 287

5.123 TheraJect Inc Company Overview 288

5.123.1 TheraJect Inc Pipeline Products & Ongoing Clinical Trials Overview 288

5.124 TheraSolve NV (Inactive) Company Overview 289

5.124.1 TheraSolve NV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 289

5.125 Theratech, Inc. Company Overview 290

5.125.1 Theratech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 290

5.126 Theris Medical Inc Company Overview 291

5.126.1 Theris Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 291

5.127 Thrudermic LLC Company Overview 292

5.127.1 Thrudermic LLC Pipeline Products & Ongoing Clinical Trials Overview 292

5.128 Titan Pharmaceuticals Inc Company Overview 293

5.128.1 Titan Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 293

5.129 Toa Eiyo Ltd Company Overview 294

5.129.1 Toa Eiyo Ltd Pipeline Products & Ongoing Clinical Trials Overview 294

5.130 Transcu Group Limited (Inactive) Company Overview 295

5.130.1 Transcu Group Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 295

5.131 Transdermal Delivery Solutions Corp Company Overview 296

5.131.1 Transdermal Delivery Solutions Corp Pipeline Products & Ongoing Clinical Trials Overview 296

5.132 TransPharma Medical Ltd (Inactive) Company Overview 302

5.132.1 TransPharma Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 302

5.133 Transport Pharmaceuticals Inc Company Overview 304

5.133.1 Transport Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 304

5.134 University of Helsinki Company Overview 305

5.134.1 University of Helsinki Pipeline Products & Ongoing Clinical Trials Overview 305

5.135 University of Illinois at Chicago Company Overview 306

5.135.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 306

5.136 University of South Florida Company Overview 307

5.136.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 307

5.137 University of Tokyo Company Overview 309

5.137.1 University of Tokyo Pipeline Products & Ongoing Clinical Trials Overview 309

5.138 University of Toronto Company Overview 310

5.138.1 University of Toronto Pipeline Products & Ongoing Clinical Trials Overview 310

5.139 University of Washington Company Overview 311

5.139.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 311

5.140 Vaxess Technologies Inc Company Overview 312

5.140.1 Vaxess Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 312

5.141 Vaxxas Pty Ltd Company Overview 316

5.141.1 Vaxxas Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 316

5.142 Verndari Inc Company Overview 317

5.142.1 Verndari Inc Pipeline Products & Ongoing Clinical Trials Overview 317

5.143 ViiV Healthcare UK Ltd Company Overview 318

5.143.1 ViiV Healthcare UK Ltd Pipeline Products & Ongoing Clinical Trials Overview 318

5.144 Virpax Pharmaceuticals Inc Company Overview 319

5.144.1 Virpax Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 319

5.145 Vyteris, Inc. (Inactive) Company Overview 323

5.145.1 Vyteris, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 323

5.146 Wellfully Ltd Company Overview 324

5.146.1 Wellfully Ltd Pipeline Products & Ongoing Clinical Trials Overview 324

5.147 Xel Pharmaceuticals Inc Company Overview 325

5.147.1 Xel Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 325

5.148 XPhyto Therapeutics Corp Company Overview 329

5.148.1 XPhyto Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 329

5.149 Zambon Italia Srl Company Overview 330

5.149.1 Zambon Italia Srl Pipeline Products & Ongoing Clinical Trials Overview 330

5.150 Z-Cube Srl Company Overview 331

5.150.1 Z-Cube Srl Pipeline Products & Ongoing Clinical Trials Overview 331

5.151 ZetrOZ Inc Company Overview 332

5.151.1 ZetrOZ Inc Pipeline Products & Ongoing Clinical Trials Overview 332

5.152 Zosano Pharma Corp Company Overview 333

5.152.1 Zosano Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview 333

5.153 Zylo Therapeutics LLC Company Overview 335

5.153.1 Zylo Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 335

5.154 Zynerba Pharmaceuticals Inc Company Overview 336

5.154.1 Zynerba Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 336

6 Transdermal Drug Delivery- Recent Developments 337

6.1 Jul 18, 2022: GSK Notice of General Meeting 337

6.2 Jul 06, 2022: Aequus signs exclusive distribution agreement with SCOPE Ophthalmics for Canadian distribution rights of dry eye products 337

6.3 Jul 01, 2022: Aequus Provides General Update and Reports Record 2021 Financial Results 337

6.4 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 338

6.5 Jun 03, 2022: Lilly to Participate in Goldman Sachs Global Healthcare Conference 339

6.6 Jun 03, 2022: Eli Lilly announces its new president and general manager for Latam 339

6.7 May 30, 2022: GSK announces further appointments to designate Haleon Board 339

6.8 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 341

6.9 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 341

6.10 May 16, 2022: Miravo Healthcare Announces First Quarter 2022 Results 341

6.11 May 12, 2022: Camurus’ interim report January-March 2022 344

6.12 May 10, 2022: 3M Annual Meeting Highlights Strong 2021, Investments for Future 345

6.13 May 06, 2022: Mary Lynne Hedley Elected to Lilly Board of Directors 346

6.14 May 04, 2022: Dyve Biosciences to Present at the UBS Global Healthcare Conference 347

6.15 May 03, 2022: Lilly to Participate in Bank of America Securities 2022 Healthcare Conference 347

6.16 May 03, 2022: Receipt of Research & Development Tax Incentive 348

6.17 May 02, 2022: Miravo Healthcare Announces First Quarter 2022 Results Release Date and Virtual Annual Meeting of Shareholders 348

6.18 Apr 28, 2022: UCB’s General Meeting of Shareholders 2022 349

6.19 Apr 27, 2022: GlaxoSmithKline announces 1st Quarter Results 350

6.20 Apr 22, 2022: Aequus Announces Director Resignation 351

6.21 Apr 11, 2022: KalVista Pharmaceuticals to Present at 21st Annual Needham Virtual Healthcare Conference 351

6.22 Apr 06, 2022: Camurus annual report for 2021 351

6.23 Mar 30, 2022: Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update 352

6.24 Mar 28, 2022: Norgine announces appointment of Alan Butcher as Chief Corporate Development Officer 354

6.25 Mar 28, 2022: Miravo Healthcare Announces 2021 and Fourth Quarter Results 354

6.26 Mar 28, 2022: GlaxoSmithKline announces Publication of 2022 AGM Notice 357

6.27 Mar 28, 2022: Norgine B.V. announces appointment of Alan Butcher as Chief Corporate Development Officer 358

6.28 Mar 23, 2022: LTS announces retirement of Werner Luscher and the appointment of Ulrich Sielaff as the company’s Chief Financial Officer 358

6.29 Mar 23, 2022: DURECT Corp. to Present at the 2022 Cantor Fitzgerald Virtual Rare Orphan Disease Summit 359

6.30 Mar 15, 2022: GSK announces appointments to Designate Haleon Board 359

6.31 Mar 15, 2022: GlaxoSmithKline announces Appointments to Designate Haleon Board 362

6.32 Mar 10, 2022: Watson Pharmaceutical Announces Postponing the Replacement and Election of Independent Directors 365

6.33 Mar 07, 2022: Durect Reports Fourth Quarter and Full Year 2021 Financial Results and Update of Programs 365

6.34 Mar 04, 2022: Glaxosmithkline Announces Publishes Annual Report 2021 366

6.35 Mar 02, 2022: Sumitomo Dainippon Pharma Announces Changes in Executive Officers Including Representative Director, Organizational Realignment and Personnel Changes 367

6.36 Feb 28, 2022: Miravo Healthcare to Present at Q1 Virtual Investor Summit 367

6.37 Feb 28, 2022: Revance Reports Fourth Quarter and Full Year 2021 Financial Results, Provides Corporate Update 367

6.38 Feb 09, 2022: GlaxoSmithKline announces Final Results 369

6.39 Jan 25, 2022: 3M Reports Fourth-Quarter and Full-Year 2021 Results 372

6.40 Jan 22, 2022: 3M MMM to Release Earnings on Tuesday 375

6.41 Jan 19, 2022: Tony Wood appointed Chief Scientific Officer designate, GSK 375

6.42 Jan 18, 2022: Nutriband expands product development pipeline for its AVERSA platform abuse deterrent technology 377

6.43 Jan 11, 2022: GSK elevates marketing’s role with key senior leadership appointments 377

6.44 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference 378

6.45 Dec 17, 2021: Norgine announces Senior Management changes 378

6.46 Dec 17, 2021: Norgine Announces Senior Management changes 378

6.47 Dec 14, 2021: DURECT Expands Board of Directors with Appointment of Biopharmaceutical Industry Finance Veteran Peter Garcia 379

6.48 Nov 30, 2021: GSK appoints Phil Dormitzer M.D., Ph.D., as Global Head of Vaccines R&D 379

6.49 Nov 16, 2021: Nemera to build state-of-the-art manufacturing facility in Poland to serve more customers and patients 380

6.50 Nov 15, 2021: Miravo Healthcare Announces Third Quarter 2021 Results 381

6.51 Nov 09, 2021: Revance Reports Third Quarter 2021 Financial Results, Provides Corporate Update 382

6.52 Nov 04, 2021: Antares Pharma Reports Third Quarter 2021 Financial and Operating Results 385

6.53 Nov 02, 2021: DURECT Corporation Reports financial results for the three months ended September 30, 2021 387

6.54 Oct 27, 2021: GlaxoSmithKline announces third Quarter Results 388

6.55 Oct 26, 2021: 3M Reports Third-Quarter 2021 Results 390

6.56 Oct 11, 2021: GSK unveils plan for UK headquarters of new Consumer Healthcare company 392

6.57 Oct 05, 2021: Norgine celebrates 30 years of the bowel preparations used in colonoscopy to help prevent and diagnose gastrointestinal diseases, including colorectal cancer 393

6.58 Sep 08, 2021: Antares Pharma to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference 394

6.59 Aug 31, 2021: Lilly to Participate in Citi’s 16th Annual BioPharma Virtual Conference 394

6.60 Aug 17, 2021: SRDDS MOU between Samyang Holdings Biopharmaceuticals Division and G2GBIO 394

6.61 Aug 09, 2021: Miravo Healthcare Announces Second Quarter 2021 Results 395

6.62 Aug 05, 2021: Antares Pharma Reports Second Quarter 2021 Financial and Operating Results 397

6.63 Aug 05, 2021: Revance Reports Second Quarter 2021 Financial Results, Provides Corporate Update 399

6.64 Jul 29, 2021: Revance to Release Second Quarter 2021 Financial Results on Thursday, August 5, 2021 401

6.65 Jul 28, 2021: Teva Reports Second Quarter 2021 Financial Results 401

6.66 Jul 28, 2021: Antares Pharma to Report Second Quarter 2021 Financial and Operating Results 403

6.67 Jul 28, 2021: 3m announces Half-year Report 404

6.68 Jul 27, 2021: 3M reports second-quarter 2021 results 405

6.69 Jul 26, 2021: Miravo Healthcare Announces Second Quarter 2021 Results Release Date and Conference Call Details 406

7 Appendix 408

7.1 Methodology 408

7.2 About GlobalData 411

7.3 Contact Us 411

7.4 Disclaimer 411

List of Tables

Transdermal Drug Delivery – Pipeline Products by Stage of Development 28

Transdermal Drug Delivery – Pipeline Products by Segment 29

Transdermal Drug Delivery – Pipeline Products by Territory 30

Transdermal Drug Delivery – Pipeline Products by Regulatory Path 32

Transdermal Drug Delivery – Pipeline Products by Estimated Approval Date 33

Transdermal Drug Delivery – Ongoing Clinical Trials 34

Transdermal Drug Delivery Companies – Pipeline Products by Stage of Development 35

Transdermal Drug Delivery – Pipeline Products by Stage of Development 41

4P Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 48

4P Clonidine Transdermal Patch – Product Status 48

4P Clonidine Transdermal Patch – Product Description 49

4P Lidocaine Transdermal Patch – Product Status 49

4P Lidocaine Transdermal Patch – Product Description 49

4P Scopolamine Transdermal Patch – Product Status 50

4P Scopolamine Transdermal Patch – Product Description 50

Aversa – Product Status 50

Aversa – Product Description 51

Aversa Buprenorphine Patch – Product Status 51

Aversa Buprenorphine Patch – Product Description 51

Aversa Methylphenidate Patch – Product Status 52

Aversa Methylphenidate Patch – Product Description 52

Transdermal Apomorphine Patch – Product Status 52

Transdermal Apomorphine Patch – Product Description 53

Transdermal Exenatide Patch – Product Status 53

Transdermal Exenatide Patch – Product Description 53

Transdermal FSH Patch – Product Status 54

Transdermal FSH Patch – Product Description 54

Transdermal Patch – Chronic Pain – Product Status 54

Transdermal Patch – Chronic Pain – Product Description 55

Transdermal Patch – Diabetes – Product Status 55

Transdermal Patch – Diabetes – Product Description 55

Transdermal Patch – Migraine – Product Status 56

Transdermal Patch – Migraine – Product Description 56

Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 57

GentleDispense System – Product Status 57

GentleDispense System – Product Description 57

Adynxx Inc Pipeline Products & Ongoing Clinical Trials Overview 58

PHN Patch – Product Status 58

PHN Patch – Product Description 58

Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 59

AQS1301 – Product Status 59

AQS1301 – Product Description 60

AQS1302 – Product Status 60

AQS1302 – Product Description 60

AQS1303 – Product Status 61

AQS1303 – Product Description 61

AQS1304 – Product Status 61

AQS1304 – Product Description 62

AerMedX Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

Deposition System – Product Status 63

Deposition System – Product Description 63

Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 64

AG200-ER Patch – Product Status 64

AG200-ER Patch – Product Description 65

AG200-SP Patch – Product Status 65

AG200-SP Patch – Product Description 65

AG890 Patch – Product Status 66

AG890 Patch – Product Description 66

Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview 67

Nanotechnology-Based Transdermal Delivery System – Product Status 67

Nanotechnology-Based Transdermal Delivery System – Product Description 67

Norethindrone Transdermal Delivery System – Product Status 68

Norethindrone Transdermal Delivery System – Product Description 68

American Chemical Society Pipeline Products & Ongoing Clinical Trials Overview 69

COVID-19 Microneedle Patch – Product Status 69

COVID-19 Microneedle Patch – Product Description 69

AMW GmbH Pipeline Products & Ongoing Clinical Trials Overview 70

Anastrozole Transdermal Patch – Product Status 70

Anastrozole Transdermal Patch – Product Description 70

Rotigotine Patch – Product Status 71

Rotigotine Patch – Product Description 71

Apogee Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 72

PyraDerm – Product Status 72

PyraDerm – Product Description 72

Asahi Kasei Pharma Corp Pipeline Products & Ongoing Clinical Trials Overview 73

Teribone Microneedle Patch System – Product Status 73

Teribone Microneedle Patch System – Product Description 73

ASCIL Biopharm Pipeline Products & Ongoing Clinical Trials Overview 74

Minimally Invasive Transdermal System – Product Status 74

Minimally Invasive Transdermal System – Product Description 74

Avecho Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview 75

TPM – Diclofenac – Product Status 75

TPM – Diclofenac – Product Description 75

TPM – Lidocaine – Product Status 76

TPM – Lidocaine – Product Description 76

TPM-Oxycodone Patch – Product Status 76

TPM-Oxycodone Patch – Product Description 77

TPM-Oxymorphone Patch – Product Status 77

TPM-Oxymorphone Patch – Product Description 77

Avro Life Sciences Pipeline Products & Ongoing Clinical Trials Overview 78

OmniDerm – Product Status 78

OmniDerm – Product Description 78

Remdesivir Transdermal Patch – Product Status 79

Remdesivir Transdermal Patch – Product Description 79

Boryung Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

Donepezil Patch – Product Status 80

Donepezil Patch – Product Description 80

Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 81

BLU402 Hydrogel Patch Wart Kit – Product Status 81

BLU402 Hydrogel Patch Wart Kit – Product Description 81

Drug Delivery Patch – Product Status 82

Drug Delivery Patch – Product Description 82

Candesant Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 83

Bi-Layer Patch – Axillary Sweating – Product Status 83

Bi-Layer Patch – Axillary Sweating – Product Description 83

Bi-Layer Patch – Facial Hyperhidrosis – Product Status 84

Bi-Layer Patch – Facial Hyperhidrosis – Product Description 84

Bi-Layer Patch – Palmar Hyperhidrosis – Product Status 84

Bi-Layer Patch – Palmar Hyperhidrosis – Product Description 85

Bi-Layer Patch – Plantar Hyperhidrosis – Product Status 85

Bi-Layer Patch – Plantar Hyperhidrosis – Product Description 85

Cassava Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 86

FENROCK – Product Status 86

FENROCK – Product Description 86

CB Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 87

Pain-Patch – Product Status 87

Pain-Patch – Product Description 87

Cerimon Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 88

Topical Diclofenac Patch – Product Status 88

Topical Diclofenac Patch – Product Description 88

Chrono Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 89

Biologically-Timed Drug Delivery Device – Product Status 89

Biologically-Timed Drug Delivery Device – Product Description 89

Cipla Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

Tizanidine Transdermal Patch – Product Status 90

Tizanidine Transdermal Patch – Product Description 90

Clexio Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 91

CLE-200 – Product Status 91

CLE-200 – Product Description 91

Corium Inc Pipeline Products & Ongoing Clinical Trials Overview 92

Adlarity – Product Status 92

Adlarity – Product Description 92

Corplex Memantine Transdermal System – Product Status 93

Corplex Memantine Transdermal System – Product Description 93

Corplex Ropinirole Transdermal System – Product Status 93

Corplex Ropinirole Transdermal System – Product Description 94

MicroCor hPTH(1-34) Transdermal System – Product Status 94

MicroCor hPTH(1-34) Transdermal System – Product Description 94

MicroCor Zolmitriptan Transdermal System – Product Status 95

MicroCor Zolmitriptan Transdermal System – Product Description 95

MicroJet – Product Status 95

MicroJet – Product Description 95

Corium Inc – Ongoing Clinical Trials Overview 96

Adlarity – Phase 1 Clinical Trial of Corplex Donepezil Transdermal System for the Treatment of Alzheimer’s Disease 97

Daewoong Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 98

Donepezil Patch – Product Status 98

Donepezil Patch – Product Description 98

DBV Technologies SA Pipeline Products & Ongoing Clinical Trials Overview 99

Viaskin Milk – Product Status 99

Viaskin Milk – Product Description 100

Viaskin Peanut – Product Status 100

Viaskin Peanut – Product Description 100

Viaskin rPT – Product Status 101

Viaskin rPT – Product Description 101

DBV Technologies SA – Ongoing Clinical Trials Overview 102

Viaskin Peanut – A Double-blind, Placebo-controlled, Randomized Phase III Trial to Assess the Safety and Efficacy of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age 103

Viaskin Peanut – Open-label Follow-up Study of the PEPITES Study to Evaluate the Long-term Efficacy and Safety of Viaskin Peanut 103

DD Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 104

Transdermal Delivery System – Product Status 104

Transdermal Delivery System – Product Description 104

Delpor Inc Pipeline Products & Ongoing Clinical Trials Overview 105

Risperidone Subcutaneous Implant – Product Status 105

Risperidone Subcutaneous Implant – Product Description 105

Tizanidine Implant – Product Status 106

Tizanidine Implant – Product Description 106

Delpor Inc – Ongoing Clinical Trials Overview 107

Risperidone Subcutaneous Implant – Open-Label Study in Stable Schizophrenia Patients to Evaluate the Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant: DLP-114 108

Dermisonics Inc Pipeline Products & Ongoing Clinical Trials Overview 109

U-Strip – Product Status 109

U-Strip – Product Description 109

Dharma Therapeutics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 110

Iontophoretic Drug Delivery Patch – Product Status 110

Iontophoretic Drug Delivery Patch – Product Description 110

Diomics Corp Pipeline Products & Ongoing Clinical Trials Overview 111

Diocheck Antibody Indicator – Product Status 111

Diocheck Antibody Indicator – Product Description 111

Drexel University Pipeline Products & Ongoing Clinical Trials Overview 112

Ultrasonically Assisted Transcutaneous Drug Delivery Device – Product Status 112

Ultrasonically Assisted Transcutaneous Drug Delivery Device – Product Description 112

Drug Delivery Co LLC Pipeline Products & Ongoing Clinical Trials Overview 113

Bio Absorbable Drug Delivery System – Product Status 113

Bio Absorbable Drug Delivery System – Product Description 113

DURECT Corp Pipeline Products & Ongoing Clinical Trials Overview 114

Eladur – Product Status 114

Eladur – Product Description 114

TRANSDUR – Sufentanil – Product Status 115

TRANSDUR – Sufentanil – Product Description 115

Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 116

Prelude SkinPrep System – Product Status 116

Prelude SkinPrep System – Product Description 116

Emplicure AB Pipeline Products & Ongoing Clinical Trials Overview 117

Micro-needle Patch – Product Status 117

Micro-needle Patch – Product Description 117

Endo International Plc Pipeline Products & Ongoing Clinical Trials Overview 118

Rivastigmine Patch – Product Status 118

Rivastigmine Patch – Product Description 118

Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview 119

AVF Gel – Product Status 119

AVF Gel – Product Description 119

Extend Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 120

Non-Invasive Needle-Free Skin Patch – Product Status 120

Non-Invasive Needle-Free Skin Patch – Product Description 120

Fe3 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 121

Iron Supplement Patch – Product Status 121

Iron Supplement Patch – Product Description 121

Futura Medical Plc Pipeline Products & Ongoing Clinical Trials Overview 122

DermaSys – Product Status 122

DermaSys – Product Description 123

DermaSys – OTC – Product Status 123

DermaSys – OTC – Product Description 123

Futura Medical Plc – Ongoing Clinical Trials Overview 124

DermaSys – A Multi-centre, Randomised, Open-label, Home Use, Parallel Group, Clinical Investigation of Topically-applied MED3000 Gel and Oral Tadalafil (5 mg) Tablets for the Treatment of Erectile Dysfunction (ED) Over a 24 Week Period 125

Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 126

Micron – Scale Arcing Device – Product Status 126

Micron – Scale Arcing Device – Product Description 126

Microneedle Patch – Measles – Product Status 127

Microneedle Patch – Measles – Product Description 127

Microneedle Patch – Polio – Product Status 127

Microneedle Patch – Polio – Product Description 128

Microneedle Patch – Rubella – Product Status 128

Microneedle Patch – Rubella – Product Description 128

Georgia State University Pipeline Products & Ongoing Clinical Trials Overview 129

Microneedle Patch – Flu – Product Status 129

Microneedle Patch – Flu – Product Description 129

GlobeStar Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 130

Transdermal PGE-1 Patch – Product Status 130

Transdermal PGE-1 Patch – Product Description 130

Hisamitsu Pharmaceutical Co Inc Pipeline Products & Ongoing Clinical Trials Overview 131

HP-1010 Adhesive Skin Patch – Product Status 131

HP-1010 Adhesive Skin Patch – Product Description 132

HP-1030 Adhesive Skin Patch – Product Status 132

HP-1030 Adhesive Skin Patch – Product Description 132

HP-5000 Adhesive Skin Patch – Product Status 133

HP-5000 Adhesive Skin Patch – Product Description 133

HP-5070 Adhesive Skin Patch – Product Status 133

HP-5070 Adhesive Skin Patch – Product Description 134

HTU-520 Patch – Product Status 134

HTU-520 Patch – Product Description 134

Zicthoru Tape – Product Status 135

Zicthoru Tape – Product Description 135

I M Sechenov Moscow State Medical University Pipeline Products & Ongoing Clinical Trials Overview 136

Anti-Cancer Patch – Product Status 136

Anti-Cancer Patch – Product Description 136

Icure Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview 137

Doneseive Patch – Product Status 137

Doneseive Patch – Product Description 138

Fomoterol Patch – Product Status 138

Fomoterol Patch – Product Description 138

Melatonin Patch – Product Status 139

Melatonin Patch – Product Description 139

Physostigmine Patch – Product Status 139

Physostigmine Patch – Product Description 140

Pramipexole Patch – Product Status 140

Pramipexole Patch – Product Description 140

ImmunoMatrix LLC Pipeline Products & Ongoing Clinical Trials Overview 141

ImmunoMatrix – Product Status 141

ImmunoMatrix – Product Description 141

ImmuPatch Pipeline Products & Ongoing Clinical Trials Overview 142

Coated ImmuPatch – Product Status 142

Coated ImmuPatch – Product Description 142

Dissolvable ImmuPatch – Product Status 142

Dissolvable ImmuPatch – Product Description 143

Indian Institute of Science Pipeline Products & Ongoing Clinical Trials Overview 144

Drug Delivery Patch – Product Status 144

Drug Delivery Patch – Product Description 144

Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 145

Poly (n-Vinyl Caprolactam) Based Patch – Product Status 145

Poly (n-Vinyl Caprolactam) Based Patch – Product Description 145

Indian Institute of Technology Hyderabad Pipeline Products & Ongoing Clinical Trials Overview 146

Transdermal Mucoadhesive Patch – Product Status 146

Transdermal Mucoadhesive Patch – Product Description 146

InMed Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 147

INM-755 – Drug Delivery Device – Product Status 147

INM-755 – Drug Delivery Device – Product Description 147

Institute of Materials Research & Engineering Pipeline Products & Ongoing Clinical Trials Overview 148

Skin Breaching Device – Product Status 148

Skin Breaching Device – Product Description 148

Intercell AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 149

Travelers Diarrhea Vaccine Patch – Product Status 149

Travelers Diarrhea Vaccine Patch – Product Description 149

Interstitial NS Pipeline Products & Ongoing Clinical Trials Overview 150

NanoMAP – Product Status 150

NanoMAP – Product Description 150

Isis Biopolymer Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 151

Gentle Touch – Product Status 151

Gentle Touch – Product Description 151

IsisIQ CLI – Product Status 152

IsisIQ CLI – Product Description 152

Janisys Pipeline Products & Ongoing Clinical Trials Overview 153

Janisys Drug Delivery System – Product Status 153

Janisys Drug Delivery System – Product Description 153

Jiaxing Xinwen Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 154

Transdermal Patch – Neurology – Product Status 154

Transdermal Patch – Neurology – Product Description 154

Transdermal Patch – Pain – Product Status 155

Transdermal Patch – Pain – Product Description 155

Jubilee Biotech Pipeline Products & Ongoing Clinical Trials Overview 156

JUBIwatch – Product Status 156

JUBIwatch – Product Description 156

Kailian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 157

Foarnnova – Product Status 157

Foarnnova – Product Description 157

Karolinska Institute Pipeline Products & Ongoing Clinical Trials Overview 158

Microneedle Patch – MRSA – Product Status 158

Microneedle Patch – MRSA – Product Description 158

Kindeva Drug Delivery LP Pipeline Products & Ongoing Clinical Trials Overview 159

Hollow Microstructured Transdermal System – Product Status 159

Hollow Microstructured Transdermal System – Product Description 159

KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 160

Microneedle Skin Patch – Product Status 160

Microneedle Skin Patch – Product Description 160

Leo Pharma AS Pipeline Products & Ongoing Clinical Trials Overview 161

Microneedle Patch – Psoriasis – Product Status 161

Microneedle Patch – Psoriasis – Product Description 161

Leo Pharma AS – Ongoing Clinical Trials Overview 162

Microneedle Patch – Psoriasis – Evaluate Safety and Efficacy of Microarray Patches in Treatment of Subjects with Psoriasis Treatment 163

Livzon Pharmaceutical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 164

Asenapine TTS – Product Status 164

Asenapine TTS – Product Description 164

Lohmann Therapie-Systeme AG Pipeline Products & Ongoing Clinical Trials Overview 165

Intradermal Microneedle Patch – Product Status 165

Intradermal Microneedle Patch – Product Description 165

Smart Patch – Product Status 166

Smart Patch – Product Description 166

Luye Pharma Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 167

Apleek – Product Status 167

Apleek – Product Description 167

Buprenorphine 3D Patch – Product Status 168

Buprenorphine 3D Patch – Product Description 168

Rivalif – Product Status 168

Rivalif – Product Description 169

Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 170

Microneedle Patch – Melanoma – Product Status 170

Microneedle Patch – Melanoma – Product Description 170

Mayne Pharma Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 171

Motion Sickness Transdermal Delivery System Patch – Product Status 171

Motion Sickness Transdermal Delivery System Patch – Product Description 171

Medherant Ltd Pipeline Products & Ongoing Clinical Trials Overview 172

Diclofenac TEPI Patch – Product Status 172

Diclofenac TEPI Patch – Product Description 172

Donepezil TEPI Patch – Product Status 173

Donepezil TEPI Patch – Product Description 173

Dronabinol TEPI Patch – Product Status 173

Dronabinol TEPI Patch – Product Description 174

Ibuprofen TEPI Patch – Product Status 174

Ibuprofen TEPI Patch – Product Description 174

Lidocaine TEPI Patch – Product Status 175

Lidocaine TEPI Patch – Product Description 175

Memantine TEPI Patch – Product Status 175

Memantine TEPI Patch – Product Description 176

Methyl Salicylate TEPI Patch – Product Status 176

Methyl Salicylate TEPI Patch – Product Description 176

MEDRx Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 177

Donepezil Patch – Product Status 177

Donepezil Patch – Product Description 178

Etoreat – Product Status 178

Etoreat – Product Description 178

Lydolyte – Product Status 179

Lydolyte – Product Description 179

MRX-1OXT Patch – Product Status 179

MRX-1OXT Patch – Product Description 180

MRX-4TZT Patch – Product Status 180

MRX-4TZT Patch – Product Description 180

MRX-7LAT Lidocaine Patch – Product Status 181

MRX-7LAT Lidocaine Patch – Product Description 181

MRX-7MLL – Product Status 181

MRX-7MLL – Product Description 182

MRX-9FLT Patch – Product Status 182

MRX-9FLT Patch – Product Description 182

MedRx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 183

KENZAN Microneedle Array – Product Status 183

KENZAN Microneedle Array – Product Description 183

Microdermics Inc Pipeline Products & Ongoing Clinical Trials Overview 184

Microneedle Drug Delivery System – Product Status 184

Microneedle Drug Delivery System – Product Description 184

Micron Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 185

Microneedle Patch – Contraception – Product Status 185

Microneedle Patch – Contraception – Product Description 185

Microneedle Patch – Virus Infection – Product Status 186

Microneedle Patch – Virus Infection – Product Description 186

Micron Biomedical Inc – Ongoing Clinical Trials Overview 187

Microneedle Patch – Virus Infection – A Phase I/II, Double-blind, Randomized, Active-controlled, Age De-escalation Trial to Assess Safety and Immunogenicity of a Measles Rubella Vaccine (MRV) Microneedle Patch (MRV-MNP) in Adults, MRV-primed Toddlers, and MRV-naive Infants 188

Micropoint Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 189

Drug-Coated Micropoint Patch – Product Status 189

Drug-Coated Micropoint Patch – Product Description 189

Mineed Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 190

Detachable and Dissolvable Microneedle Patch – Product Status 190

Detachable and Dissolvable Microneedle Patch – Product Description 190

mPhase Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 191

Smart Drug Delivery System – Product Status 191

Smart Drug Delivery System – Product Description 191

Mycrodose Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 192

Psilocin Transdermal Drug Delivery System – Product Status 192

Psilocin Transdermal Drug Delivery System – Product Description 192

Transdermal Drug Delivery System – LSD – Product Status 193

Transdermal Drug Delivery System – LSD – Product Description 193

MyLife Technologies Pipeline Products & Ongoing Clinical Trials Overview 194

Ceramic Vaccine Patch – Product Status 194

Ceramic Vaccine Patch – Product Description 194

Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview 195

Skin Pressure Device – Product Status 195

Skin Pressure Device – Product Description 195

National Dental Centre Singapore Pipeline Products & Ongoing Clinical Trials Overview 196

MN Patch – Product Status 196

MN Patch – Product Description 196

National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 197

Microneedle Granule – Drug Delivery – Product Status 197

Microneedle Granule – Drug Delivery – Product Description 197

Microneedle Skin Patch – Product Status 198

Microneedle Skin Patch – Product Description 198

Nemaura Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 199

Memspatch – Product Status 199

Memspatch – Product Description 200

Microneedle Drug Delivery Device – Product Status 200

Microneedle Drug Delivery Device – Product Description 200

Micropatch – Product Status 201

Micropatch – Product Description 201

Mycrolator – Product Status 201

Mycrolator – Product Description 202

Transdermal Patch – Alzheimer’s Disease – Product Status 202

Transdermal Patch – Alzheimer’s Disease – Product Description 202

Transdermal Patch – Buprenorphine – Product Status 203

Transdermal Patch – Buprenorphine – Product Description 203

Transdermal Patch – Diclofenac – Product Status 203

Transdermal Patch – Diclofenac – Product Description 203

Transdermal Patch – Hypertension – Product Status 204

Transdermal Patch – Hypertension – Product Description 204

Transdermal Patch – Nicotine – Product Status 204

Transdermal Patch – Nicotine – Product Description 205

Transdermal Patch – Parkinson’s Disease – Product Status 205

Transdermal Patch – Parkinson’s Disease – Product Description 205

Transdermal Patch – Rivastigmine – Product Status 206

Transdermal Patch – Rivastigmine – Product Description 206

NeuroDerm Ltd Pipeline Products & Ongoing Clinical Trials Overview 207

ND0601 Dermal Patch – Product Status 207

ND0601 Dermal Patch – Product Description 207

ND0611 Dermal Patch – Product Status 208

ND0611 Dermal Patch – Product Description 208

Nitto Denko Corp Pipeline Products & Ongoing Clinical Trials Overview 209

Transdermal Enoxaparin Sodium Patch – Product Status 209

Transdermal Enoxaparin Sodium Patch – Product Description 209

Transdermal Fentanyl Citrate Patch – Product Status 210

Transdermal Fentanyl Citrate Patch – Product Description 210

Transdermal Protein Patch – Product Status 210

Transdermal Protein Patch – Product Description 211

North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 212

Antibody Delivery Microneedle Patch – Product Status 212

Antibody Delivery Microneedle Patch – Product Description 212

Intraconazole Microneedle – Product Status 213

Intraconazole Microneedle – Product Description 213

Skin Patch – Melanoma – Product Status 213

Skin Patch – Melanoma – Product Description 213

Noven Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 214

ATS Adhesive Skin Patch – Product Status 214

ATS Adhesive Skin Patch – Product Description 214

Lidocaine Topical Patch – Product Status 215

Lidocaine Topical Patch – Product Description 215

NutriBand Inc Pipeline Products & Ongoing Clinical Trials Overview 216

Ciprofloxacin Transdermal Patch – Product Status 216

Ciprofloxacin Transdermal Patch – Product Description 216

TD00A1 – Transdermal Drug Delivery System – Product Status 217

TD00A1 – Transdermal Drug Delivery System – Product Description 217

TD00G1 – Transdermal Drug Delivery System – Product Status 217

TD00G1 – Transdermal Drug Delivery System – Product Description 218

TD0CD1/TD0CD2 – Transdermal Drug Delivery System – Product Status 218

TD0CD1/TD0CD2 – Transdermal Drug Delivery System – Product Description 218

TD0ID1 – Transdermal Drug Delivery System – Product Status 219

TD0ID1 – Transdermal Drug Delivery System – Product Description 219

TD0IJD – Transdermal Drug Delivery System – Product Status 219

TD0IJD – Transdermal Drug Delivery System – Product Description 220

Nuvo Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 221

Alprazolam Patch – Product Status 221

Alprazolam Patch – Product Description 221

Osprey Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 222

Limb Recovery System – Product Status 222

Limb Recovery System – Product Description 222

Pantec Biosolutions AG Pipeline Products & Ongoing Clinical Trials Overview 223

P.L.E.A.S.E. Diclofenac/Lidocaine Device – Product Status 223

P.L.E.A.S.E. Diclofenac/Lidocaine Device – Product Description 223

P.L.E.A.S.E. IT Device – Product Status 224

P.L.E.A.S.E. IT Device – Product Description 224

P.L.E.A.S.E. Mobile – Product Status 224

P.L.E.A.S.E. Mobile – Product Description 225

P.L.E.A.S.E. Private – Product Status 225

P.L.E.A.S.E. Private – Product Description 225

P.L.E.A.S.E. RNAi – Product Status 226

P.L.E.A.S.E. RNAi – Product Description 226

PassPort Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 227

PassPort System – Product Status 227

PassPort System – Product Description 227

PharmaTher Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 228

MacroDose-MN Patch – Product Status 228

MacroDose-MN Patch – Product Description 228

MicroDose-MN Patch – Product Status 229

MicroDose-MN Patch – Product Description 229

PHARMAPATCH – Product Status 229

PHARMAPATCH – Product Description 230

Privo Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 231

PRV Chemotherapy Patch – Product Status 231

PRV Chemotherapy Patch – Product Description 231

Prometheon Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview 232

HeatWave Patch – Product Status 232

HeatWave Patch – Product Description 232

TruePatch – Basal Insulin – Product Status 233

TruePatch – Basal Insulin – Product Description 233

TruePatch – Rapid-Acting (Bolus) Insulin – Product Status 233

TruePatch – Rapid-Acting (Bolus) Insulin – Product Description 234

Purdue University Pipeline Products & Ongoing Clinical Trials Overview 235

Flexible Elastomer Patch – Product Status 235

Flexible Elastomer Patch – Product Description 235

Pump For Drug-Delivery Patch – Product Status 236

Pump For Drug-Delivery Patch – Product Description 236

Quadmedicine Pipeline Products & Ongoing Clinical Trials Overview 237

Microneedle Drug Delivery Device – Obesity – Product Status 237

Microneedle Drug Delivery Device – Obesity – Product Description 237

Microneedle Drug Delivery Device – Osteoporosis – Product Status 238

Microneedle Drug Delivery Device – Osteoporosis – Product Description 238

Quoin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 239

QRX001 – Product Status 239

QRX001 – Product Description 239

QRX002 – Product Status 240

QRX002 – Product Description 240

Radius Health Inc Pipeline Products & Ongoing Clinical Trials Overview 241

Tymlos Patch – Product Status 241

Tymlos Patch – Product Description 241

Ryah Medtech Inc Pipeline Products & Ongoing Clinical Trials Overview 242

RYAH Smart-Patch – Product Status 242

RYAH Smart-Patch – Product Description 242

Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 243

Rheumastop S Hot – Product Status 243

Rheumastop S Hot – Product Description 243

Sanofi Pipeline Products & Ongoing Clinical Trials Overview 244

Reflectech – Product Status 244

Reflectech – Product Description 244

Seelos Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 245

Second Generation Vitaros Room Temperature Device – Product Status 245

Second Generation Vitaros Room Temperature Device – Product Description 245

Shenox Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview 246

SHX-001 – Product Status 246

SHX-001 – Product Description 246

SHX-002 – Product Status 247

SHX-002 – Product Description 247

SHX-003 – Product Status 247

SHX-003 – Product Description 247

SHX-009 – Product Status 248

SHX-009 – Product Description 248

Shenox Pharmaceuticals LLC – Ongoing Clinical Trials Overview 249

SHX-001 – A Phase 1 Pharmacokinetics and Pharmacodynamics of Ketamine Transdermal Drug Delivery System in Subjects with Sub-optimally Responsive Major Depressive Disorders 250

Sinsin Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 251

SS-261 – Product Status 251

SS-261 – Product Description 251

SS-510 – Product Status 252

SS-510 – Product Description 252

SS-620 – Product Status 252

SS-620 – Product Description 252

SS-631 – Product Status 253

SS-631 – Product Description 253

SK Chemicals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 254

Wondron Patch – Product Status 254

Wondron Patch – Product Description 254

Skinject Inc Pipeline Products & Ongoing Clinical Trials Overview 255

SkinJect PatchIT – Product Status 255

SkinJect PatchIT – Product Description 255

Skinject Inc – Ongoing Clinical Trials Overview 256

SkinJect PatchIT – A Trial to Evaluate Placebo Microneedle Arrays in Healthy Human Volunteers (Part I), Followed by Proof of Concept Testing of Efficacy and Safety of Doxorubicin Microneedle Arrays in Subjects with Basal Cell Cancer (Part II) 257

Sorrento Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 258

MuVaxx Lymphatic Drug Delivery Device – Product Status 258

MuVaxx Lymphatic Drug Delivery Device – Product Description 258

Sparsha Pharma International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 259

5-HT3 Receptor Antagonist Patch – Product Status 259

5-HT3 Receptor Antagonist Patch – Product Description 259

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 260

Micro Needle Patch – Product Status 260

Micro Needle Patch – Product Description 260

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 261

Dissolving Microneedle – Product Status 261

Dissolving Microneedle – Product Description 261

SARS-CoV-2 Vaccine Patch – Product Status 262

SARS-CoV-2 Vaccine Patch – Product Description 262

Starton Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 263

CMIO-DEX Transdermal Patch – Product Status 263

CMIO-DEX Transdermal Patch – Product Description 264

CMIO-DRONAB Transdermal Patch – Product Status 264

CMIO-DRONAB Transdermal Patch – Product Description 264

CMIO-OL-P – Product Status 265

CMIO-OL-P – Product Description 265

contd..

List of Figures

Transdermal Drug Delivery – Pipeline Products by Stage of Development 28

Transdermal Drug Delivery – Pipeline Products by Segment 29

Transdermal Drug Delivery – Pipeline Products by Territory 30

Transdermal Drug Delivery – Pipeline Products by Regulatory Path 32

Transdermal Drug Delivery – Pipeline Products by Estimated Approval Date 33

Transdermal Drug Delivery – Ongoing Clinical Trials 34

Frequently Asked Questions

The key territories in the transdermal drug delivery pipeline market are the United States, Europe, South Korea, Canada, Japan, China, and Australia.

The key categories in the transdermal drug delivery pipeline market are Active Formulations and Passive Formulations.

The key regulatory paths in the transdermal drug delivery pipeline market are 510(k), CE, MDITAC, MDL, Ninsho, NMPA, TGA, and BOPA. 510(k) has the highest number of pipeline products.

The key companies in the transdermal drug delivery pipeline market are 4P Therapeutics LLC, Actuated Medical Inc, Adynxx Inc, Aequus Pharmaceuticals Inc, AerMedX Ltd, and Agile Therapeutics Inc, Allergan Ltd, American Chemical Society, and AMW GmbH.

$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about our multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Testimonial

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods
Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.